Mehmet Samur

Dr. Mehmet Kemal Samur is a principal research scientist at the Dana-Farber Cancer Institute (DFCI) and Harvard TH Chan School of Public Health. With a background in computational biology, Dr. Samur’s work focuses on integrating bioinformatics, machine learning, and genomics to advance cancer research. He has contributed significantly to understanding the molecular and genetic mechanisms underlying multiple myeloma and other hematological cancers. Dr. Samur works with both clinical and research teams to develop innovative methods and data-driven insights, aiming to improve Multiple Myeloma diagnosis, prognosis, and treatment strategies.